Skip to main content
. 2025 Jun 7;25:463. doi: 10.1186/s12887-025-05824-0

Table 2.

Summary of the outcome measures

Outcome Measures Value
Number of patients initiated on insulin Infusion 24
Number of patients initiated on subcutaneous insulin 6
Duration of insulin infusion (hours) 10.72 ± 8.99
Time to pH Recovery (hours) 10.67 ± 7.85
Time to Bicarbonate Recovery (hours) 6.79 5.5 ± 4
ED Stay Duration (hours) 7.93 ± 4.80
Transfers post-ED stay

 Critical Care Unit

 Paediatric Ward

 Tertiary Care Centre

14 patients

14 patients

2 patients

Length of Hospital Stay (days)

 Insulin Infusion Group (24)

 SC Insulin Group (6)

2.18 ± 1.3

2.3

1.7

Complications Needing Intervention 3 patients
Discharge Condition All 28 patients are stable.
Follow-up post-hospitalisation at our centre 13/18 patients
Duration of Follow-Up (years) 1.65 ± 1.62
HbA1c at Last Follow-Up (%) 8.32 ± 1.80
Insulin Dose at Follow-Up (U/kg/day) 0.96
Transfers to Other Services 3 patients (2 local, 1 adult endocrine)
Loss to Follow-Up 2 patients